News
Questions are answered by experts at the Oregon Health Authority, other state agencies or community partners. Questions and ...
The company was pleased to report the findings of a late-stage clinical trial of its advanced flu vaccine. Moderna (NASDAQ: ...
Private equity firm Carlyle Group is preparing to offload up to a 10% stake in India's Piramal Pharma, online news portal Moneycontrol reported on Thursday, citing sources. The U.S.-based firm could ...
That whole meeting was a travesty,” says Fiona Havers, a physician and epidemiologist. After the ACIP firings, Havers ...
The US Advisory Committee on Immunization Practices voted in June to stop recommending certain kinds of flu vaccines, a ...
The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...
COVID-19 variant N.B.1.8.1, or Nimbus, is more contagious than recent past variants and known to cause a particularly painful ...
The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health ...
Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...
Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...
Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...
Moderna’s mRNA-based flu and covid-19 vaccine could provide the best of both worlds—if it’s actually ever approved by the Food and Drug Administration. This week, scientists at Moderna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results